Skip to content
healthcare.dev

Abiraterone Acetate

NDC 75907-224, Abiraterone Acetate, tablet, from Dr. Reddys Laboratories Inc.

Product NDC
75907-224
Status
Listed
Labeler
Dr. Reddys Laboratories Inc
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208416
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/75907-224 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABIRATERONE ACETATE250 mg/1

Pharmacologic classes

Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]

Package NDCNDC-11Package
75907-224-0475907022404120 TABLET in 1 BOTTLE (75907-224-04)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0c91aa38-3b0a-232c-8eb1-55f08e8e6644
  • NADAC price for package 75907022404

    GET /v1/drugs/nadac/75907022404

Use it

Look up 75907-224 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/75907-224 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 75907-224. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.